Determinación de la susceptibilidad a la vancomicina en cepas de Staphylococcus aureus meticilino-resistente (SARM) aisladas en un hospital de tercer nivel de complejidad de Medellín mediante varias pruebas de sensibilidad antimicrobiana
ABSTRACT: Vancomycin has been the most effective antibiotic against infections caused by methicillin resistant Staphylococcus aureus (MRSA). To date there are no reports of Intermediate Vancomycin-Intermediate Staphylococcus aureus (VISA) or Vancomycin-Resistant Staphylococcus aureus (VRSA) in Colom...
- Autores:
-
Ocampo Ríos, Ana Maria
Echeverri Toro, Lina María
Jiménez Quiceno, Judy Natalia
- Tipo de recurso:
- Article of investigation
- Fecha de publicación:
- 2012
- Institución:
- Universidad de Antioquia
- Repositorio:
- Repositorio UdeA
- Idioma:
- spa
- OAI Identifier:
- oai:bibliotecadigital.udea.edu.co:10495/11065
- Acceso en línea:
- http://hdl.handle.net/10495/11065
- Palabra clave:
- Resistencia a la Vancomicina
Vancomycin Resistance
Vancomicina
Vancomycin
- Rights
- openAccess
- License
- https://creativecommons.org/licenses/by/2.5/co/
| id |
UDEA2_28e0705141cb08f7fcca1e9aa6da7adf |
|---|---|
| oai_identifier_str |
oai:bibliotecadigital.udea.edu.co:10495/11065 |
| network_acronym_str |
UDEA2 |
| network_name_str |
Repositorio UdeA |
| repository_id_str |
|
| dc.title.spa.fl_str_mv |
Determinación de la susceptibilidad a la vancomicina en cepas de Staphylococcus aureus meticilino-resistente (SARM) aisladas en un hospital de tercer nivel de complejidad de Medellín mediante varias pruebas de sensibilidad antimicrobiana |
| dc.title.translated.spa.fl_str_mv |
Vancomycin susceptibility determination through various antimicrobial susceptibility tests in Methicillin-resistant Staphylococcus aureus (MRSA) strains isolated from a tertiary care hospital in Medellín. |
| title |
Determinación de la susceptibilidad a la vancomicina en cepas de Staphylococcus aureus meticilino-resistente (SARM) aisladas en un hospital de tercer nivel de complejidad de Medellín mediante varias pruebas de sensibilidad antimicrobiana |
| spellingShingle |
Determinación de la susceptibilidad a la vancomicina en cepas de Staphylococcus aureus meticilino-resistente (SARM) aisladas en un hospital de tercer nivel de complejidad de Medellín mediante varias pruebas de sensibilidad antimicrobiana Resistencia a la Vancomicina Vancomycin Resistance Vancomicina Vancomycin |
| title_short |
Determinación de la susceptibilidad a la vancomicina en cepas de Staphylococcus aureus meticilino-resistente (SARM) aisladas en un hospital de tercer nivel de complejidad de Medellín mediante varias pruebas de sensibilidad antimicrobiana |
| title_full |
Determinación de la susceptibilidad a la vancomicina en cepas de Staphylococcus aureus meticilino-resistente (SARM) aisladas en un hospital de tercer nivel de complejidad de Medellín mediante varias pruebas de sensibilidad antimicrobiana |
| title_fullStr |
Determinación de la susceptibilidad a la vancomicina en cepas de Staphylococcus aureus meticilino-resistente (SARM) aisladas en un hospital de tercer nivel de complejidad de Medellín mediante varias pruebas de sensibilidad antimicrobiana |
| title_full_unstemmed |
Determinación de la susceptibilidad a la vancomicina en cepas de Staphylococcus aureus meticilino-resistente (SARM) aisladas en un hospital de tercer nivel de complejidad de Medellín mediante varias pruebas de sensibilidad antimicrobiana |
| title_sort |
Determinación de la susceptibilidad a la vancomicina en cepas de Staphylococcus aureus meticilino-resistente (SARM) aisladas en un hospital de tercer nivel de complejidad de Medellín mediante varias pruebas de sensibilidad antimicrobiana |
| dc.creator.fl_str_mv |
Ocampo Ríos, Ana Maria Echeverri Toro, Lina María Jiménez Quiceno, Judy Natalia |
| dc.contributor.author.none.fl_str_mv |
Ocampo Ríos, Ana Maria Echeverri Toro, Lina María Jiménez Quiceno, Judy Natalia |
| dc.contributor.researchgroup.spa.fl_str_mv |
Microbiología Molecular |
| dc.subject.decs.none.fl_str_mv |
Resistencia a la Vancomicina Vancomycin Resistance |
| topic |
Resistencia a la Vancomicina Vancomycin Resistance Vancomicina Vancomycin |
| dc.subject.lemb.none.fl_str_mv |
Vancomicina Vancomycin |
| description |
ABSTRACT: Vancomycin has been the most effective antibiotic against infections caused by methicillin resistant Staphylococcus aureus (MRSA). To date there are no reports of Intermediate Vancomycin-Intermediate Staphylococcus aureus (VISA) or Vancomycin-Resistant Staphylococcus aureus (VRSA) in Colombia; however there is a high prevalence of MRSA and increased vancomycin use, which are contributing factors to their emergence. Additionally, routine methods used for detection of these strains such as automated and disc diffusion have limitations. OBJECTIVE To evaluate vancomycin susceptibility in a collection of MRSA strains isolated from patients between 2008-2010 in a University hospital of Medellin. MATERIALS AND METHODS 150 MRSA isolates were selected. The vancomycin minimum inhibitory concentration (MIC) was performed by Vitek-2 and Etest. Additionally, vancomycin screen agar plates were employed. RESULTS All of the isolates tested were susceptible to vancomycin, however, differences between the evaluated methods were observed: the 59.3% of the isolates (n = 89) showed an MIC ≤ 1 µg/mL by Etest, whereas by Vitek2, only the 22% (n = 33) of the isolates had this value. CONCLUSIONS We found a significant number of isolates with an MIC ≤ 1 µg/mL, which have been associated with increased risk of treatment failure. These results show the relevance of permanent surveillance of antibiotic resistance, to achieve the establishment of appropriate control strategies. comycin has been the most effective antibiotic against infections caused by methicillin resistant Staphylococcus aureus (MRSA). To date there are no reports of Intermediate Vancomycin-Intermediate Staphylococcus aureus (VISA) or Vancomycin-Resistant Staphylococcus aureus (VRSA) in Colombia; however there is a high prevalence of MRSA and increased vancomycin use, which are contributing factors to their emergence. Additionally, routine methods used for detection of these strains such as automated and disc diffusion have limitations. Key words: Antimicrobial Susceptibility Testing. Methicillin-resistant Staphylococcus aureus (MRSA). Resistance. Vancomycin. |
| publishDate |
2012 |
| dc.date.issued.none.fl_str_mv |
2012 |
| dc.date.accessioned.none.fl_str_mv |
2019-05-17T20:49:51Z |
| dc.date.available.none.fl_str_mv |
2019-05-17T20:49:51Z |
| dc.type.spa.fl_str_mv |
Artículo de investigación |
| dc.type.coar.spa.fl_str_mv |
http://purl.org/coar/resource_type/c_2df8fbb1 |
| dc.type.redcol.spa.fl_str_mv |
https://purl.org/redcol/resource_type/ART |
| dc.type.coarversion.spa.fl_str_mv |
http://purl.org/coar/version/c_970fb48d4fbd8a85 |
| dc.type.driver.spa.fl_str_mv |
info:eu-repo/semantics/article |
| dc.type.version.spa.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
| format |
http://purl.org/coar/resource_type/c_2df8fbb1 |
| status_str |
publishedVersion |
| dc.identifier.citation.spa.fl_str_mv |
Ocampo AM, Echeverri LM, Jiménez JN. Determinación de la susceptibilidad a la vancomicina en cepas de Staphylococcus aureus meticilino-resistente (SARM) aisladas en un hospital de tercer nivel de complejidad de Medellín mediante varias pruebas de sensibilidad antimicrobiana. Hechos Microbiol. 2012;3(1);41-48. |
| dc.identifier.issn.none.fl_str_mv |
2145-8898 |
| dc.identifier.uri.none.fl_str_mv |
http://hdl.handle.net/10495/11065 |
| identifier_str_mv |
Ocampo AM, Echeverri LM, Jiménez JN. Determinación de la susceptibilidad a la vancomicina en cepas de Staphylococcus aureus meticilino-resistente (SARM) aisladas en un hospital de tercer nivel de complejidad de Medellín mediante varias pruebas de sensibilidad antimicrobiana. Hechos Microbiol. 2012;3(1);41-48. 2145-8898 |
| url |
http://hdl.handle.net/10495/11065 |
| dc.language.iso.spa.fl_str_mv |
spa |
| language |
spa |
| dc.relation.ispartofjournalabbrev.spa.fl_str_mv |
Hechos Microbiol. |
| dc.relation.citationendpage.spa.fl_str_mv |
48 |
| dc.relation.citationissue.spa.fl_str_mv |
1 |
| dc.relation.citationstartpage.spa.fl_str_mv |
41 |
| dc.relation.citationvolume.spa.fl_str_mv |
3 |
| dc.relation.ispartofjournal.spa.fl_str_mv |
Hechos Microbiológicos |
| dc.rights.uri.*.fl_str_mv |
https://creativecommons.org/licenses/by/2.5/co/ |
| dc.rights.uri.spa.fl_str_mv |
https://creativecommons.org/licenses/by/4.0/ |
| dc.rights.accessrights.*.fl_str_mv |
Atribución 2.5 Colombia (CC BY 2.5 CO) |
| dc.rights.accessrights.spa.fl_str_mv |
info:eu-repo/semantics/openAccess |
| dc.rights.coar.spa.fl_str_mv |
http://purl.org/coar/access_right/c_abf2 |
| rights_invalid_str_mv |
https://creativecommons.org/licenses/by/2.5/co/ https://creativecommons.org/licenses/by/4.0/ Atribución 2.5 Colombia (CC BY 2.5 CO) http://purl.org/coar/access_right/c_abf2 |
| eu_rights_str_mv |
openAccess |
| dc.format.mimetype.spa.fl_str_mv |
application/pdf |
| dc.publisher.spa.fl_str_mv |
Universidad de Antioquia, Escuela de Microbiología |
| dc.publisher.place.spa.fl_str_mv |
Medellín, Colombia |
| institution |
Universidad de Antioquia |
| bitstream.url.fl_str_mv |
https://bibliotecadigital.udea.edu.co/bitstreams/80c937bf-a5a3-4165-9f25-504918390f83/download https://bibliotecadigital.udea.edu.co/bitstreams/3556e8ea-56b7-41f8-b963-5143a831a7c4/download https://bibliotecadigital.udea.edu.co/bitstreams/df07b1e8-5ba6-40a1-a692-2552614f6285/download https://bibliotecadigital.udea.edu.co/bitstreams/1c81a174-ceb3-46a1-aa6f-b0e876564dcb/download https://bibliotecadigital.udea.edu.co/bitstreams/5dd72ef0-fba4-477b-9724-c040722a623d/download https://bibliotecadigital.udea.edu.co/bitstreams/a4b90c23-a046-475b-b3d7-527020fc8615/download https://bibliotecadigital.udea.edu.co/bitstreams/e36458ff-3924-4a96-a229-5dd098dab523/download |
| bitstream.checksum.fl_str_mv |
b3fef01f5f1ed4250d1f5f29ed61c09b 4afdbb8c545fd630ea7db775da747b2f d41d8cd98f00b204e9800998ecf8427e d41d8cd98f00b204e9800998ecf8427e 8a4605be74aa9ea9d79846c1fba20a33 76aed26e53093dedff01eedfd982aa4b 678961d239757d5647daf54d7d2050a9 |
| bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 MD5 MD5 MD5 MD5 MD5 |
| repository.name.fl_str_mv |
Repositorio Institucional de la Universidad de Antioquia |
| repository.mail.fl_str_mv |
aplicacionbibliotecadigitalbiblioteca@udea.edu.co |
| _version_ |
1851052479695814656 |
| spelling |
Ocampo Ríos, Ana MariaEcheverri Toro, Lina MaríaJiménez Quiceno, Judy NataliaMicrobiología Molecular2019-05-17T20:49:51Z2019-05-17T20:49:51Z2012Ocampo AM, Echeverri LM, Jiménez JN. Determinación de la susceptibilidad a la vancomicina en cepas de Staphylococcus aureus meticilino-resistente (SARM) aisladas en un hospital de tercer nivel de complejidad de Medellín mediante varias pruebas de sensibilidad antimicrobiana. Hechos Microbiol. 2012;3(1);41-48.2145-8898http://hdl.handle.net/10495/11065ABSTRACT: Vancomycin has been the most effective antibiotic against infections caused by methicillin resistant Staphylococcus aureus (MRSA). To date there are no reports of Intermediate Vancomycin-Intermediate Staphylococcus aureus (VISA) or Vancomycin-Resistant Staphylococcus aureus (VRSA) in Colombia; however there is a high prevalence of MRSA and increased vancomycin use, which are contributing factors to their emergence. Additionally, routine methods used for detection of these strains such as automated and disc diffusion have limitations. OBJECTIVE To evaluate vancomycin susceptibility in a collection of MRSA strains isolated from patients between 2008-2010 in a University hospital of Medellin. MATERIALS AND METHODS 150 MRSA isolates were selected. The vancomycin minimum inhibitory concentration (MIC) was performed by Vitek-2 and Etest. Additionally, vancomycin screen agar plates were employed. RESULTS All of the isolates tested were susceptible to vancomycin, however, differences between the evaluated methods were observed: the 59.3% of the isolates (n = 89) showed an MIC ≤ 1 µg/mL by Etest, whereas by Vitek2, only the 22% (n = 33) of the isolates had this value. CONCLUSIONS We found a significant number of isolates with an MIC ≤ 1 µg/mL, which have been associated with increased risk of treatment failure. These results show the relevance of permanent surveillance of antibiotic resistance, to achieve the establishment of appropriate control strategies. comycin has been the most effective antibiotic against infections caused by methicillin resistant Staphylococcus aureus (MRSA). To date there are no reports of Intermediate Vancomycin-Intermediate Staphylococcus aureus (VISA) or Vancomycin-Resistant Staphylococcus aureus (VRSA) in Colombia; however there is a high prevalence of MRSA and increased vancomycin use, which are contributing factors to their emergence. Additionally, routine methods used for detection of these strains such as automated and disc diffusion have limitations. Key words: Antimicrobial Susceptibility Testing. Methicillin-resistant Staphylococcus aureus (MRSA). Resistance. Vancomycin.RESUMEN: La vancomicina ha sido el antibiótico más eficaz contra las infecciones causadas por Staphylococcus aureus resistente a la meticilina (SARM). En Colombia, hasta la fecha, no se han reportado aislamientos con sensibilidad intermedia o resistentes a vancomicina, no obstante se presenta una prevalencia alta de SAMR y un alto consumo de vancomicina, condiciones que favorecerían su aparición. Adicionalmente, los métodos automatizados y de difusión en disco, empleados de rutina para la detección de estas cepas presentan limitaciones. OBJETIVO Determinar la susceptibilidad a vancomicina en una colección de aislamientos de SARM obtenidos de pacientes durante los años 2008-2010 en un hospital universitario de la ciudad de Medellín. MATERIALES Y MÉTODOS Se seleccionaron 150 aislamientos de SARM en los cuales la susceptibilidad a vancomicina se determinó empleando agar de tamización BHI-vancomicina y la concentración Inhibitoria mínima (CIM) se determinó por Vitek-2 y Etest. RESULTADOS La totalidad de los aislamientos evaluados fueron sensibles a vancomicina. Se observaron diferencias entre los métodos evaluados, 59,3% de los aislamientos (n=89), presentaron una CIM ≤ 1 µg/mL, por Etest, mientras que por Vitek2 solo el 22% (n=33) presentaron este valor. CONCLUSIÓN Se determinó un numero importante de aislamientos con una CIM ≤ 1 µg/mL, las cuales se han asociado con mayor riesgo de falla terapéutica. Estos resultados evidencian la importancia de establecer una vigilancia constante de la resistencia a antibióticos, para lograr el establecimiento de estrategias adecuadas de control. Palabras clave: Pruebas de susceptibilidad antimicrobiana. Staphylococcus aureus meticilino resistente (SARM). Resistencia. Vancomicina.COL0126131application/pdfspaUniversidad de Antioquia, Escuela de MicrobiologíaMedellín, Colombiahttps://creativecommons.org/licenses/by/2.5/co/https://creativecommons.org/licenses/by/4.0/Atribución 2.5 Colombia (CC BY 2.5 CO)info:eu-repo/semantics/openAccesshttp://purl.org/coar/access_right/c_abf2Determinación de la susceptibilidad a la vancomicina en cepas de Staphylococcus aureus meticilino-resistente (SARM) aisladas en un hospital de tercer nivel de complejidad de Medellín mediante varias pruebas de sensibilidad antimicrobianaVancomycin susceptibility determination through various antimicrobial susceptibility tests in Methicillin-resistant Staphylococcus aureus (MRSA) strains isolated from a tertiary care hospital in Medellín.Artículo de investigaciónhttp://purl.org/coar/resource_type/c_2df8fbb1https://purl.org/redcol/resource_type/ARThttp://purl.org/coar/version/c_970fb48d4fbd8a85info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionResistencia a la VancomicinaVancomycin ResistanceVancomicinaVancomycinHechos Microbiol.481413Hechos MicrobiológicosPublicationORIGINALOcampoAna_2012_SusceptibilidadVancomicina.pdfOcampoAna_2012_SusceptibilidadVancomicina.pdfArtículo de investigaciónapplication/pdf1007582https://bibliotecadigital.udea.edu.co/bitstreams/80c937bf-a5a3-4165-9f25-504918390f83/downloadb3fef01f5f1ed4250d1f5f29ed61c09bMD51trueAnonymousREADCC-LICENSElicense_urllicense_urltext/plain; charset=utf-849https://bibliotecadigital.udea.edu.co/bitstreams/3556e8ea-56b7-41f8-b963-5143a831a7c4/download4afdbb8c545fd630ea7db775da747b2fMD52falseAnonymousREADlicense_textlicense_texttext/html; charset=utf-80https://bibliotecadigital.udea.edu.co/bitstreams/df07b1e8-5ba6-40a1-a692-2552614f6285/downloadd41d8cd98f00b204e9800998ecf8427eMD53falseAnonymousREADlicense_rdflicense_rdfLicenciaapplication/rdf+xml; charset=utf-80https://bibliotecadigital.udea.edu.co/bitstreams/1c81a174-ceb3-46a1-aa6f-b0e876564dcb/downloadd41d8cd98f00b204e9800998ecf8427eMD54falseAnonymousREADLICENSElicense.txtlicense.txttext/plain; charset=utf-81748https://bibliotecadigital.udea.edu.co/bitstreams/5dd72ef0-fba4-477b-9724-c040722a623d/download8a4605be74aa9ea9d79846c1fba20a33MD55falseAnonymousREADTEXTOcampoAna_2012_SusceptibilidadVancomicina.pdf.txtOcampoAna_2012_SusceptibilidadVancomicina.pdf.txtExtracted texttext/plain35707https://bibliotecadigital.udea.edu.co/bitstreams/a4b90c23-a046-475b-b3d7-527020fc8615/download76aed26e53093dedff01eedfd982aa4bMD56falseAnonymousREADTHUMBNAILOcampoAna_2012_SusceptibilidadVancomicina.pdf.jpgOcampoAna_2012_SusceptibilidadVancomicina.pdf.jpgGenerated Thumbnailimage/jpeg10318https://bibliotecadigital.udea.edu.co/bitstreams/e36458ff-3924-4a96-a229-5dd098dab523/download678961d239757d5647daf54d7d2050a9MD57falseAnonymousREAD10495/11065oai:bibliotecadigital.udea.edu.co:10495/110652025-03-26 23:00:10.583https://creativecommons.org/licenses/by/2.5/co/open.accesshttps://bibliotecadigital.udea.edu.coRepositorio Institucional de la Universidad de Antioquiaaplicacionbibliotecadigitalbiblioteca@udea.edu.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 |
